Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Tuberculosis

  • your selections
Clear Search

Filter Results

date

Tags

  • results
PLOS Article Highlights Innovative TB Case Detection Projects

The Center for Global Health Policy’s “Science Speaks” blog examines an article published in PLOS ONE highlighting projects and new approaches aimed at increasing TB case detection. The blog notes, “The gains yielded by those projects [funded through the Stop TB Partnership's TB Reach] show what added funding and ‘fresh thinking’ can…

Blog Discusses Future Of Development Assistance For Global Health

Writing in the Health Affairs Blog, Jennifer Kates, vice president and director of Global Health & HIV Policy at the Kaiser Family Foundation, discusses findings from a new analysis by Dielemen et al. on global health funding. Kates notes the analysis raises “important questions about the future for policymakers, particularly those in…

Global Fund’s TB, Malaria Efforts In China Reveal ‘Mixed Legacy’

Writing in the Council on Foreign Relations’ (CFR) “Asia Unbound” blog, Yanzhong Huang, senior fellow for global health at CFR, discusses TB control and malaria eradication efforts in China, noting that while efforts to control these two diseases have been successful, “a comparison of the role of the Global Fund…

UNICEF, Global Fund Coordinate Efforts To Improve Maternal, Child Health

In a press release, UNICEF and the Global Fund to Fight AIDS, Tuberculosis and Malaria announced a new agreement “to better coordinate efforts aimed at reducing the burden of HIV, tuberculosis, and malaria and improving the health of mothers, newborns, and children. … Under the new agreement, the Global Fund and…

Gates Foundation Backing Phase III Clinical Trial Of New TB Drug Regimen

News outlets report on the announcement of a Phase III clinical trial for a drug regimen that has the potential to fight drug-resistant tuberculosis. The Guardian: New and better treatments for drug-resistant tuberculosis on the horizon “A new trial of a novel drug combination that could dramatically shorten treatment for…

New Drug Regimen Aims To Transform TB Treatment, Improve Health

“The first-ever drug regimen designed to treat both drug-sensitive TB and MDR-TB [multidrug-resistant TB] has reached a critical milestone and will advance to a global Phase III clinical trial — the last, but most important stage of testing before it can be made available,” Mel Spigelman, president and CEO of…

U.N.-Backed Initiative Expands Efforts To Drive Medical Innovations For NTDs

U.N. News Centre: U.N.-backed initiative boosts knowledge-sharing to combat neglected tropical diseases “Announcing that more than 50 partners are now on board its partnership initiative to fight against neglected tropical diseases, tuberculosis, and malaria, the United Nations intellectual property agency today hailed the watershed achievement as a significant step towards…

J&J Announces Collaboration With Stop TB Partnership To Improve Access To TB Drug

Media sources report on efforts by Johnson & Johnson to improve access to Sirturo, its medication for drug-resistant tuberculosis (TB). Bloomberg News: J&J Eases Access for Tuberculosis Drug in Poor Nations “Johnson & Johnson is taking steps to ensure Sirturo, its medicine for people with drug-resistant tuberculosis, is available and…

Forbes Examines Innovative Financing, UNITAID

Forbes: Meet The Man With A Simple, Workable Solution To World Poverty: Innovative Financing The magazine interviews Philippe Douste-Blazy about innovative financing and UNITAID. “…[R]eferred to by former U.S. President Bill Clinton as ‘France’s gift to the world,’ [UNITAID] is one of the first major initiatives to be largely funded…

U.S. Congress Should Increase Funding For International TB Programs, Drug Research

Cleveland.com: Funding for tuberculosis programs on chopping block Joanne Carter, executive director of RESULTS Educational Fund “A new drug regimen for tuberculosis — a global epidemic that kills about 1.3 million people each year — has the potential to cut treatment times and costs dramatically. … With U.S. government funding…